News from October 2016

Studies assessing the effectiveness of anti-viral treatments for swine flu and those seeking to understand the behaviour of the virus, must factor in the route of infection during experiments, as this has a greater impact on results than previously thought, a new study from The Pirbright Institute…

Scientists at The Pirbright Institute have been encouraged by the results from a potential new vaccine candidate against Marek’s disease (MD). Using a recombinant (new combinations of genetic material) adenovirus which carries a single gene from a virulent strain of Marek’s disease virus, they are…

Training is a key part of The Pirbright Institute’s mission and each year the Institute offers a diverse range of research projects for prospective PhD students. During their time at Pirbright, students would normally attend (and hopefully present at), at least one international conference -…

The full potential of genetic modification or GM technology to tackle some of the world’s most dangerous diseases is still not being realised well over a decade after it was first developed. The lack of effective international regulation, regional variations in public opinion and uncertainties about…